The pharmacologically active compound that psilocybin converts to in the body, responsible for psychedelic effects.
Psilocin (4-hydroxy-N,N-dimethyltryptamine or 4-HO-DMT) is the pharmacologically active metabolite of psilocybin. While psilocybin is often discussed as the "active ingredient" in magic mushrooms, it is actually psilocin that produces the psychedelic experience by directly interacting with brain receptors.
Psilocin has the molecular formula C₁₂H₁₆N₂O. It differs from psilocybin by lacking the phosphate group, which makes it less stable but able to cross the blood-brain barrier. Psilocin is also naturally present in some mushroom species, though typically in lower concentrations than psilocybin.
Psilocin primarily exerts its effects by binding to serotonin receptors in the brain, particularly the 5-HT2A receptor. This binding triggers a cascade of effects:
Because psilocybin must first convert to psilocin, effects typically begin 20-60 minutes after ingestion. Peak effects occur around 1-2 hours and gradually subside over 4-6 hours. The conversion rate can vary based on individual metabolism, stomach contents, and other factors.
Different mushroom strains contain different ratios of psilocybin to psilocin. Strains with higher natural psilocin content may have faster onset times. However, psilocin degrades more quickly than psilocybin, so older or improperly stored mushrooms may have reduced potency.
Understanding psilocin helps explain several practical aspects of the mushroom experience. The conversion from psilocybin to psilocin explains why effects don't begin immediately—your body needs time to metabolize the prodrug. It also explains why eating on an empty stomach typically produces faster, more intense effects (faster conversion), and why lemon tek (soaking mushrooms in lemon juice) can accelerate onset (the acidic environment begins the conversion process before ingestion). For those interested in the science, psilocin's action on serotonin receptors connects magic mushrooms to the broader field of psychedelic research and helps explain both the subjective effects and therapeutic potential.